SEC Company Response from MEDICINOVA INC (MNOV) (CIK 0001226616) (MNOV) — Aug 20, 2019
MEDICINOVA INC (MNOV) (CIK 0001226616)
Date: Aug. 20, 2019 · CIK: 0001226616 · Accession: 0001193125-19-225366
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233201
Letter
Re: Acceleration Request of MediciNova, Inc.
August 20, 2019
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Donald Field
Registration Statement on Form S-3, filed August 9, 2019
(File No. 333-233201)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Thursday, August 22, 2019, or as soon thereafter as practicable.
Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060.
Very truly yours,
MediciNova, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
August 20, 2019
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street,
N.E.
Washington, D.C. 20549
Attention:
Mr. Donald Field
Re:
Acceleration Request of MediciNova, Inc.
Registration Statement on Form S-3, filed August 9, 2019
(File No. 333-233201)
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, MediciNova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement, to
4:00 p.m., Eastern Time, on Thursday, August 22, 2019, or as soon thereafter as practicable.
Thank you for your assistance. If
you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060.
Very truly yours,
MediciNova, Inc.
/s/ Yuichi Iwaki, M.D., Ph.D.
Yuichi Iwaki, M.D., Ph.D.
President and Chief Executive Officer